SV40 Capsids Protect Mice from Kidney Failure
Author Information
Author(s): Butin-Israeli Veronika, Uzi Dotan, Abd-El-Latif Mahmoud, Pizov Galina, Eden Arieh, Haviv Yosef S., Oppenheim Ariella
Primary Institution: Hebrew University-Hadassah Medical School, Jerusalem, Israel
Hypothesis
Can SV40 empty capsids induce protective signaling pathways to prevent acute kidney injury?
Conclusion
SV40 VLPs significantly improve survival rates and reduce kidney damage in mice with acute kidney injury.
Supporting Evidence
- VLPs increased survival rates from 12% to 63% in mice with acute kidney injury.
- Serum urea and creatinine levels were significantly lower in VLP-treated mice compared to untreated mice.
- VLPs activated key survival pathways in kidney cells, reducing apoptosis.
Takeaway
Scientists found that a virus without DNA can help protect mice from kidney damage, making them healthier after being sick.
Methodology
Mice were treated with SV40 VLPs before being exposed to mercury to induce acute kidney injury, and their survival and kidney function were assessed.
Potential Biases
Potential bias in the interpretation of results due to the use of a single animal model.
Limitations
The study primarily used a mouse model, which may not fully replicate human responses to SV40 VLPs.
Participant Demographics
Balb/C female mice, 8–10 weeks old.
Statistical Information
P-Value
2×10−6
Confidence Interval
95% CI: 2.07–7.91
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website